Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study

DOI record: { "DOI": "10.1016/j.ebiom.2020.102999", "ISSN": [ "2352-3964" ], "URL": "http://dx.doi.org/10.1016/j.ebiom.2020.102999", "alternative-id": [ "S2352396420303753" ], "article-number": "102999", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study" }, { "label": "Journal Title", "name": "journaltitle", "value": "EBioMedicine" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ebiom.2020.102999" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 The Authors. Published by Elsevier B.V." } ], "author": [ { "affiliation": [], "family": "Masiá", "given": "Mar", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0001-9949-8504", "affiliation": [], "authenticated-orcid": false, "family": "Fernández-González", "given": "Marta", "sequence": "additional" }, { "affiliation": [], "family": "Padilla", "given": "Sergio", "sequence": "additional" }, { "affiliation": [], "family": "Ortega", "given": "Piedad", "sequence": "additional" }, { "affiliation": [], "family": "García", "given": "José A.", "sequence": "additional" }, { "affiliation": [], "family": "Agulló", "given": "Vanesa", "sequence": "additional" }, { "affiliation": [], "family": "García-Abellán", "given": "Javier", "sequence": "additional" }, { "affiliation": [], "family": "Telenti", "given": "Guillermo", "sequence": "additional" }, { "affiliation": [], "family": "Guillén", "given": "Lucía", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-9485-6867", "affiliation": [], "authenticated-orcid": false, "family": "Gutiérrez", "given": "Félix", "sequence": "additional" } ], "container-title": "EBioMedicine", "container-title-short": "EBioMedicine", "content-domain": { "crossmark-restriction": true, "domain": [ "thelancet.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 9, 16 ] ], "date-time": "2020-09-16T12:23:13Z", "timestamp": 1600258993000 }, "deposited": { "date-parts": [ [ 2020, 10, 19 ] ], "date-time": "2020-10-19T09:07:56Z", "timestamp": 1603098476000 }, "funder": [ { "award": [ "RD16/0025/0038" ], "name": "Instituto de Salud Carlos III - Subdirección General de Evaluación y Fondo Europeo de Desarrollo Regional" }, { "DOI": "10.13039/501100004587", "award": [ "PI16/01740", "PI18/01861", "CM19/00160", "COV20-00005" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100004587", "id-type": "DOI" } ], "name": "Instituto de Salud Carlos III" } ], "indexed": { "date-parts": [ [ 2025, 4, 29 ] ], "date-time": "2025-04-29T09:08:57Z", "timestamp": 1745917737223, "version": "3.37.3" }, "is-referenced-by-count": 63, "issued": { "date-parts": [ [ 2020, 10 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 10, 1 ] ], "date-time": "2020-10-01T00:00:00Z", "timestamp": 1601510400000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 8, 28 ] ], "date-time": "2020-08-28T00:00:00Z", "timestamp": 1598572800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2352396420303753?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2352396420303753?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "102999", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 10 ] ] }, "published-print": { "date-parts": [ [ 2020, 10 ] ] }, "publisher": "Elsevier BV", "reference": [ { "article-title": "Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients", "author": "Zhou", "journal-title": "Natl Sci Rev", "key": "10.1016/j.ebiom.2020.102999_bib0001", "year": "2020" }, { "DOI": "10.1016/j.intimp.2005.05.010", "article-title": "Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family", "author": "Mihara", "doi-asserted-by": "crossref", "first-page": "1731", "journal-title": "Int Immunopharmacol", "key": "10.1016/j.ebiom.2020.102999_bib0002", "volume": "5", "year": "2005" }, { "DOI": "10.1186/s12967-020-02339-3", "article-title": "Why tocilizumab could be an effective treatment for severe COVID-19", "author": "Fu", "doi-asserted-by": "crossref", "first-page": "164", "journal-title": "J Transl Med", "key": "10.1016/j.ebiom.2020.102999_bib0003", "volume": "18", "year": "2020" }, { "DOI": "10.1073/pnas.2005615117", "article-title": "Effective treatment of severe COVID-19 patients with tocilizumab", "author": "Xu", "doi-asserted-by": "crossref", "first-page": "10970", "journal-title": "Proc Natl Acad Sci USA", "key": "10.1016/j.ebiom.2020.102999_bib0004", "volume": "117", "year": "2020" }, { "DOI": "10.1016/j.autrev.2020.102568", "article-title": "Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy", "author": "Toniati", "doi-asserted-by": "crossref", "journal-title": "Autoimmun Rev", "key": "10.1016/j.ebiom.2020.102999_bib0005", "volume": "19", "year": "2020" }, { "DOI": "10.1016/S2665-9913(20)30173-9", "article-title": "Tocilizumab in patients with severe COVID-19: a retrospective cohort study", "author": "Guaraldi", "doi-asserted-by": "crossref", "journal-title": "Lancet Rheumatol", "key": "10.1016/j.ebiom.2020.102999_bib0006", "year": "2020" }, { "article-title": "IL-6 signal transduction and its physiological roles: the signal orchestration model. Reviews of physiology", "author": "Kamimura", "first-page": "1", "journal-title": "Biochem Pharmacol", "key": "10.1016/j.ebiom.2020.102999_bib0007", "volume": "149", "year": "2003" }, { "DOI": "10.1146/annurev.immunol.23.021704.115806", "article-title": "Interleukin-6: from basic science to medicine-40 years in immunology", "author": "Kishimoto", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Annu Rev Immunol", "key": "10.1016/j.ebiom.2020.102999_bib0008", "volume": "23", "year": "2005" }, { "DOI": "10.1016/j.jbspin.2017.02.010", "article-title": "Monitoring of Epstein–Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis", "author": "Scherlinger", "doi-asserted-by": "crossref", "first-page": "259", "journal-title": "Joint Bone Spine", "key": "10.1016/j.ebiom.2020.102999_bib0009", "volume": "85", "year": "2018" }, { "DOI": "10.3201/eid1706.101057", "article-title": "Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy", "author": "Van Duin", "doi-asserted-by": "crossref", "first-page": "754", "journal-title": "Emerg Infect Dis", "key": "10.1016/j.ebiom.2020.102999_bib0010", "volume": "17", "year": "2011" }, { "DOI": "10.1016/j.jbspin.2010.07.009", "article-title": "Serious herpes zoster in rheuma-toid arthritis under anti-interleukin-6 receptor antibody", "author": "Kubandova", "doi-asserted-by": "crossref", "journal-title": "Joint Bone Spine", "key": "10.1016/j.ebiom.2020.102999_bib0011", "volume": "77", "year": "2010" }, { "article-title": "Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients", "author": "Chen", "first-page": "[in press]", "journal-title": "Clin Infect Dis", "key": "10.1016/j.ebiom.2020.102999_bib0012", "year": "2020" }, { "DOI": "10.1084/jem.167.2.332", "article-title": "The essential role of B cell stimulatory factor (BSF-2/IL-6) for the terminal differentiation of B cells", "author": "Muraguchi", "doi-asserted-by": "crossref", "first-page": "332", "journal-title": "J Exp Med", "key": "10.1016/j.ebiom.2020.102999_bib0013", "volume": "15", "year": "1988" }, { "DOI": "10.1111/j.1600-065X.1997.tb01011.x", "article-title": "Cytokines and immunity to viral infections", "author": "Ramshaw", "doi-asserted-by": "crossref", "first-page": "119", "journal-title": "Immunol Rev", "key": "10.1016/j.ebiom.2020.102999_bib0014", "volume": "159", "year": "1997" }, { "DOI": "10.1038/nrrheum.2017.83", "article-title": "The role of IL-6 in host defence against infections: immunobiology and clinical implications", "author": "Rose-John", "doi-asserted-by": "crossref", "first-page": "399", "journal-title": "Nat Rev Rheumatol", "key": "10.1016/j.ebiom.2020.102999_bib0015", "volume": "13", "year": "2017" }, { "DOI": "10.1038/368339a0", "article-title": "Impaired immune and acute-phase responses in interleukin-6-deficient mice", "author": "Kopf", "doi-asserted-by": "crossref", "first-page": "339", "journal-title": "Nature", "key": "10.1016/j.ebiom.2020.102999_bib0016", "volume": "368", "year": "1994" }, { "DOI": "10.1016/j.jbspin.2015.07.009", "article-title": "Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis", "author": "Mourgues", "doi-asserted-by": "crossref", "first-page": "412", "journal-title": "Joint Bone Spine", "key": "10.1016/j.ebiom.2020.102999_bib0017", "volume": "83", "year": "2016" }, { "DOI": "10.1007/s00296-011-2060-2", "article-title": "Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection", "author": "Nagashima", "doi-asserted-by": "crossref", "first-page": "2231", "journal-title": "Rheumatol Int", "key": "10.1016/j.ebiom.2020.102999_bib0018", "volume": "32", "year": "2012" }, { "DOI": "10.1136/bmj.m1443", "article-title": "Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study", "author": "Zheng", "doi-asserted-by": "crossref", "journal-title": "BMJ", "key": "10.1016/j.ebiom.2020.102999_bib0019", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "author": "Zhou", "doi-asserted-by": "crossref", "first-page": "1054", "journal-title": "Lancet", "key": "10.1016/j.ebiom.2020.102999_bib0020", "volume": "395", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30232-2", "article-title": "Viral dynamics in mild and severe cases of COVID-19", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "656", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.ebiom.2020.102999_bib0021", "volume": "20", "year": "2020" }, { "DOI": "10.1080/23744235.2020.1748705", "article-title": "Duration of SARS-CoV-2 viral shedding during COVID-19 infection", "author": "Qian", "doi-asserted-by": "crossref", "first-page": "511", "journal-title": "Infect Dis (Lond)", "key": "10.1016/j.ebiom.2020.102999_bib0022", "volume": "52", "year": "2020" }, { "DOI": "10.1186/ar4358", "article-title": "Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis", "author": "Crnkic Kapetanovic", "doi-asserted-by": "crossref", "first-page": "R171", "journal-title": "Arthritis Res Ther", "key": "10.1016/j.ebiom.2020.102999_bib0023", "volume": "15", "year": "2013" }, { "DOI": "10.1136/annrheumdis-2012-201950", "article-title": "Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis", "author": "Mori", "doi-asserted-by": "crossref", "first-page": "2006", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.ebiom.2020.102999_bib0024", "volume": "71", "year": "2012" }, { "DOI": "10.1136/annrheumdis-2013-204427", "article-title": "Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)", "author": "Bingham", "doi-asserted-by": "crossref", "first-page": "818", "journal-title": "Ann Rheum Dis", "key": "10.1016/j.ebiom.2020.102999_bib0025", "volume": "74", "year": "2015" }, { "DOI": "10.1080/22221751.2020.1756699", "article-title": "Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients", "author": "Yongchen", "doi-asserted-by": "crossref", "first-page": "833", "journal-title": "Emerg Microbes Infect", "key": "10.1016/j.ebiom.2020.102999_bib0026", "volume": "9", "year": "2020" }, { "DOI": "10.1093/cid/ciaa344", "article-title": "Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019", "author": "Zhao", "doi-asserted-by": "crossref", "journal-title": "Clin Infect Dis", "key": "10.1016/j.ebiom.2020.102999_bib0027", "year": "2020" }, { "DOI": "10.1038/s41591-020-0897-1", "article-title": "Antibody responses to SARS-CoV-2 in patients with COVID-19", "author": "Long", "doi-asserted-by": "crossref", "first-page": "845", "journal-title": "Nat Med", "key": "10.1016/j.ebiom.2020.102999_bib0028", "volume": "26", "year": "2020" }, { "DOI": "10.1084/jem.20102065", "article-title": "B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells", "author": "Lee", "doi-asserted-by": "crossref", "first-page": "1377", "journal-title": "J Exp Med", "key": "10.1016/j.ebiom.2020.102999_bib0029", "volume": "208", "year": "2011" }, { "DOI": "10.1073/pnas.0403492101", "article-title": "Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity", "author": "Buchholz", "doi-asserted-by": "crossref", "first-page": "9804", "journal-title": "Proc Natl Acad Sci USA", "key": "10.1016/j.ebiom.2020.102999_bib0030", "volume": "101", "year": "2004" } ], "reference-count": 30, "references-count": 30, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2352396420303753" } }, "score": 1, "short-title": [], "source": "Crossref", "special_numbering": "C", "subject": [], "subtitle": [], "title": "Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "60" }